LSA
ASXC

Leonteq Securities AG’s Asensus Surgical, Inc. ASXC Stock Holding History

Leonteq Securities AG’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-45,000
Closed -$15K – 1289
2024
Q2 		$15K Hold
45,000
– – ﹤0.01% 945
2024
Q1 		$10.3K Hold
45,000
– – ﹤0.01% 1007
2023
Q4 		$14.4K Hold
45,000
– – ﹤0.01% 971
2023
Q3 		$12.2K Hold
45,000
– – ﹤0.01% 994
2023
Q2 		$22.7K Hold
45,000
– – ﹤0.01% 956
2023
Q1 		$29.6K Hold
45,000
– – ﹤0.01% 890
2022
Q4 		$15.6K Hold
45,000
– – ﹤0.01% 999
2022
Q3 		$20.2K Sell
45,000
-20,000
-31% -$10.4K ﹤0.01% 957
2022
Q2 		$25.9K Buy
65,000
+25,000
+63% +$11.2K ﹤0.01% 944
2022
Q1 		$25.1K Sell
40,000
-10,000
-20% -$7.7K ﹤0.01% 972
2021
Q4 		$55.5K Buy
50,000
+5,000
+11% +$7.73K ﹤0.01% 887
2021
Q3 		$83.3K Buy
45,000
+25,500
+131% +$57.3K ﹤0.01% 762
2021
Q2 		$61.8K Buy
19,500
+5,500
+39% +$13.7K ﹤0.01% 804
2021
Q1 		$45.5K Buy
+14,000
New +$50.7K ﹤0.01% 795

Other funds holding ASXC

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Leonteq Securities AG's ASXC Position: Q3 2024 in Review

Leonteq Securities AG sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 45,000 shares — an estimated $15K sold.

Leonteq Securities AG first reported a position in ASXC in Q1 2021 and held it in 14 quarters. The position peaked at $83.3K in Q3 2021. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • Leonteq Securities AG reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • Leonteq Securities AG sold 45,000 Asensus Surgical, Inc. shares in Q3 2024, an estimated $15K.
  • Leonteq Securities AG first reported a position in Asensus Surgical, Inc. in Q1 2021 and held it in 14 quarters.
  • Leonteq Securities AG's Asensus Surgical, Inc. position peaked at $83.3K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Leonteq Securities AG's 13F filing for Q3 2024, filed 4 Mar 2026.